Operating Lease, Weighted Average Discount Rate, Percent of VYNE Therapeutics Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
VYNE Therapeutics Inc. quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • VYNE Therapeutics Inc. Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending 31 Dec 2024 was 0.08, unchanged year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Change (%)

VYNE Therapeutics Inc. Quarterly Operating Lease, Weighted Average Discount Rate, Percent (pure)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 0.08 0 0% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q4 2023 0.08 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q2 2022 0.131 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 0.131 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 0.131 0 0% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q4 2020 0.131 +0.0702 +115% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q4 2019 0.0608 31 Dec 2019 10-K 04 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.